А. А. Феденко

5.6k citations
92 papers · 3.7k · 6 hit papers · h-index 18

Impact in

Papers in

А. А. Феденко

63 papers receiving 3.6k citations

А. А. Феденко's Hit Papers

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial 2023 · 374 citations
3740+4+9Years since publication200400600

Peers

А. А. Феденко
Comparison fields: 5 of 87
  • Gastroenterology 854
  • Pulmonary and Respiratory Medicine 1.5k
  • Hepatology 330
  • Oncology 440
  • Rheumatology 145
Replace Anna Maria Frezza with:
Anna Maria Frezza Italy
Carlo Morosi Italy
Giovanni De Manzoni Italy
Jason B. Klapman United States
L. Chaigneau France
Silvia Gasperoni Italy
Michelle R. Mahoney United States
Akmal Safwat Denmark
Seiji Ito Japan
Ryan S. Turley United States
А. А. Феденко relative to Anna Maria Frezza Italy Anna Maria Frezza's profile →
Citations per field
00.5×1.5×2×2.4×
Anna Maria Frezza · 1×
Citations per year

Countries citing papers authored by А. А. Феденко

Since Specialization
Citations

This map shows the geographic impact of А. А. Феденко's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by А. А. Феденко with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites А. А. Феденко more than expected).

Fields of papers citing papers by А. А. Феденко

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by А. А. Феденко. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by А. А. Феденко. The network helps show where А. А. Феденко may publish in the future.

Co-authors

The 25 scholars most cited alongside А. А. Феденко, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with А. А. Феденко Line = papers co-authored together А. А. Феденко links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
Hit paper breakdown →
2021702
2
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hit paper breakdown →
2018603
3
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hit paper breakdown →
2021374
4
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Hit paper breakdown →
2023374
5
A Meta-Analysis of Osteosarcoma Outcomes in the Modern Medical Era
Hit paper breakdown →
2012356
6
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
Hit paper breakdown →
2021313
7 2020251
8 2021105
9 201594
10 201769
11 201868
12
Gastrointestinal Stromal Tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii21, 2014)
201552
13 201938
14 202137
15 202237
16 200833
17 201531
18 200325
19 201214
20 20219

About А. А. Феденко

А. А. Феденко is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine, Obstetrics and Gynecology and Rheumatology, having authored 92 papers that have together received 3.7k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (14 papers), Gastric Cancer Management and Outcomes (8 papers), Lymphoma Diagnosis and Treatment (6 papers), Endometrial and Cervical Cancer Treatments (5 papers), Bone Tumor Diagnosis and Treatments (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and COVID-19 and healthcare impacts (4 papers). The work is most often cited by research in Gastroenterology (854 citations), Pulmonary and Respiratory Medicine (1.5k citations), Hepatology (330 citations), Oncology (440 citations) and Rheumatology (145 citations). А. А. Феденко has collaborated with scholars based in Russia, United States and Italy. Frequent co-authors include Sant P. Chawla, Lawrence R. Menendez, Elke R. Ahlmann, Scott Carney, Andrew Eugene Hendifar, Daniel Christopher Allison, Kristen Nooshin Ganjoo, Zsuzsanna Pápai, Guzel Mukhametshina and Kamalesh Kumar Sankhala. Their work appears in journals such as Annals of Oncology, Frontiers in Oncology, JAMA Oncology, The Lancet and ESMO Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact